NanoHive Medical Expands into New Markets with Distribution Partner HC Trade USA

Apr 1, 2024

BOSTON, MA., April 2, 2024 – NanoHive Medical, LLC, an innovative 3D printing spinal implant technology company, has entered into a distribution agreement with HC Trade USA, a leading global medical distribution company, to represent NanoHive’s highly innovative Hive™ Soft Titanium® interbody fusion products portfolio in South American markets as well as other select international markets. The companies anticipate the first South American market sales in the second quarter of this year.

Patrick O’Donnell, President & CEO of NanoHive Medical stated, “NanoHive has made remarkable progress, particularly over the past twenty-four months, driving adoption of our technology and consistently growing our sales quarter-over-quarter primarily through our independent distribution channel in the U.S. market. We have reached the stage where it is now executable for us to enter new markets without disrupting our focus on managing rapid growth in the U.S. Based on their high caliber reputation and history of success in the spine device industry, we are very enthusiastic about the opportunity to partner with HC Trade USA on market entry and growth initiatives.”

Husnu Ceylan, President & CEO of HC Trade USA remarks, “Our markets are demanding next generation innovation at a reasonable price. We believe, having methodically assessed several products in this segment, that NanoHive’s Hive technology is significantly distinguishable and is an ideal solution for our surgeon customers. Our team is very excited to represent NanoHive’s products.”


About HC Trade USA
As an international medical and pharmaceutical product distribution company; HC Trade USA has more than 550 years of combined experience in global medical markets and has established a total global sales volume of $450M+ since 2006.

NanoHive Medical, LLC is a pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company’s proprietary, biomimetic Soft Titanium® technology clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provide surgeons and their patients ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration – all features that lead to consistently strong fusion constructs and efficacious clinical experiences.

NanoHive Medical is located in Woburn, Massachusetts U.S.A.

Contact: Patrick O’Donnell, CEO & President at